Videos / Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD
In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).
An Update on Heart Failure in Primary Care
Allergen Introduction – Practical Tips for GPs
Falls Prevention – A Practical, Evidence-Based Update on What Really Works
The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns
expert
Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals